Claritev Corp — Form 8-K
Filed October 15, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
Claritev appointed Jennifer Main as a director effective October 15, 2026, filling a newly created board seat. Main brings 30+ years of healthcare and government leadership experience, including prior roles as CMS Chief Operating Officer (2018–2021), CFO of TARP at U.S. Treasury, and current CFO roles at RealMDai and Overture Life since March 2026. This is a standard board appointment with no financial transaction or operational impact disclosed.
Why this rating
Board appointment is routine governance activity. No material financial, operational, or strategic change disclosed. Appointment is small relative to $505.8M market cap.
See more from October 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.